DRL
Location
Vlaams Brabant
Founded
1980-09-05
Website
Risk Signals
105 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Furniture, Catalog and Mail-Order Houses), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about DRL
Live alerts from global media, monitored by Business Radar
2025-07-07 (newsauto.gr)
Hybrid turn for Lamborghini Urus Performmante -
The Lamborghini Urus Performante is preparing for a hybrid upgrade with a brand new engine.
Read more
2025-04-28 (thehindubusinessline.com)
DRL to distribute Sanofi's Beyfortus, used to prevent RSV in infants - The Hindu
Dr Reddy's and Sanofi partner to launch Beyfortus, a novel drug to prevent respiratory syncytial virus in infants.
Read more
2023-04-24 (abplive.com)
Maruti Suzuki Fronx Launched In India Newest Maruti With Turbo Petrol Engine Check Prices Features Photos Details
The Fronx is a coupe SUV based on the Baleno and was first unveiled at the 2023 Auto Expo. After the Baleno RS, the Fronx is the newest Maruti to get turbo petrol.
Read more
2021-09-02 (thehindu.com)
DRL, Natco rise on nod for Revlimid copy -
Business News:DRL, Natco rise on nod for Revlimid copy
Read more
2021-06-28 (business-standard.com)
DRL launches DRDO drug 2-DG to treat moderate to severe Covid patients
Dr Reddy's Laboratories (DRL) commercially launched 2-deoxy-D-glucose (2-DG), a drug used for treating Coronavirus (Covid-19) patients, priced at Rs 990 for a...
Read more
2018-10-15 (expresspharma.in)
DRL receives US FDA approval -
The company has received the approval for Aspirin and Extended-Release dipyridamole capsules in the US Market Dr Reddy's Labs, (DRL) recently announced receipt of approval for Aspirin and Extended-Release dipyridamole capsules, […]
Read more
(economictimes.com)
DRL launches nitroglycerin sublingual tablets in US -
The drug which is used in preventing or relieving a sudden attack of angina (chest pain) caused by heart disease was approved by the USFDA.
Read more